Nicola Wealth Management LTD. lessened its holdings in shares of Itron, Inc. (NASDAQ:ITRI - Free Report) by 20.0% in the first quarter, according to its most recent filing with the SEC. The firm owned 24,000 shares of the scientific and technical instruments company's stock after selling 6,000 shares during the period. Nicola Wealth Management LTD. owned 0.05% of Itron worth $2,514,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds also recently made changes to their positions in ITRI. Strs Ohio acquired a new stake in shares of Itron during the first quarter worth $430,000. Intech Investment Management LLC boosted its holdings in Itron by 17.7% during the first quarter. Intech Investment Management LLC now owns 48,699 shares of the scientific and technical instruments company's stock worth $5,102,000 after buying an additional 7,336 shares during the last quarter. Bayforest Capital Ltd grew its position in shares of Itron by 43.9% during the 1st quarter. Bayforest Capital Ltd now owns 3,980 shares of the scientific and technical instruments company's stock worth $417,000 after buying an additional 1,215 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in shares of Itron by 129.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 732,274 shares of the scientific and technical instruments company's stock worth $76,713,000 after buying an additional 413,487 shares during the period. Finally, Optimize Financial Inc increased its stake in shares of Itron by 2.7% in the 1st quarter. Optimize Financial Inc now owns 17,570 shares of the scientific and technical instruments company's stock valued at $1,841,000 after acquiring an additional 463 shares during the last quarter. Institutional investors own 96.19% of the company's stock.
Itron Stock Performance
ITRI traded up $0.19 during trading on Wednesday, hitting $117.66. The stock had a trading volume of 109,672 shares, compared to its average volume of 592,359. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.04 and a quick ratio of 1.75. The company has a 50 day moving average price of $127.28 and a 200-day moving average price of $117.62. Itron, Inc. has a one year low of $90.11 and a one year high of $140.04. The firm has a market cap of $5.38 billion, a price-to-earnings ratio of 20.11, a P/E/G ratio of 0.66 and a beta of 1.46.
Itron (NASDAQ:ITRI - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The scientific and technical instruments company reported $1.62 EPS for the quarter, topping analysts' consensus estimates of $1.33 by $0.29. The business had revenue of $606.76 million for the quarter, compared to analyst estimates of $610.36 million. Itron had a net margin of 11.05% and a return on equity of 19.69%. Itron's revenue for the quarter was down .4% compared to the same quarter last year. During the same period last year, the firm earned $1.21 earnings per share. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. As a group, research analysts predict that Itron, Inc. will post 5.33 EPS for the current year.
Insider Transactions at Itron
In other news, SVP John F. Marcolini sold 565 shares of the stock in a transaction on Monday, August 25th. The stock was sold at an average price of $125.31, for a total transaction of $70,800.15. Following the sale, the senior vice president directly owned 14,396 shares of the company's stock, valued at approximately $1,803,962.76. This represents a 3.78% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Donald L. Reeves III sold 547 shares of the business's stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $125.31, for a total value of $68,544.57. Following the completion of the transaction, the senior vice president directly owned 19,604 shares of the company's stock, valued at approximately $2,456,577.24. This trade represents a 2.71% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 3,037 shares of company stock worth $380,566. Corporate insiders own 1.51% of the company's stock.
Wall Street Analysts Forecast Growth
A number of research analysts recently issued reports on the stock. Guggenheim restated a "buy" rating and set a $155.00 price objective (up previously from $133.00) on shares of Itron in a report on Monday, July 14th. Stephens set a $130.00 price objective on shares of Itron in a research report on Monday, August 4th. TD Cowen lifted their target price on Itron from $139.00 to $145.00 and gave the stock a "buy" rating in a report on Friday, June 20th. JPMorgan Chase & Co. upgraded Itron from a "neutral" rating to an "overweight" rating and lifted their price objective for the company from $128.00 to $145.00 in a report on Thursday, July 31st. Finally, Johnson Rice lowered Itron from a "buy" rating to an "accumulate" rating in a research report on Friday, August 1st. Ten investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $136.55.
Read Our Latest Stock Report on Itron
About Itron
(
Free Report)
Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.
Featured Stories

Before you consider Itron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.
While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.